These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
81 related items for PubMed ID: 1987893
41. [Significance of cancer cell purification determining chemosensitivities for gastric cancer cells]. Morishita T, Kato M, Nakamura T, Saitoh Y. Nihon Geka Gakkai Zasshi; 1995 Jul; 96(7):448-55. PubMed ID: 7675024 [Abstract] [Full Text] [Related]
42. Tumor implants in the mediastinum of mice. Adlersberg L, Singer JM, Edberg SC. J Reticuloendothel Soc; 1974 May; 15(5):345-60. PubMed ID: 4855274 [No Abstract] [Full Text] [Related]
43. [Establishment of transplantable human colon cancer cell lines, chemosensitivity of colon carcinomas and the serially transplantable strains with MTT assay]. Kase S, Kubota T, Furukawa T, Yamaguchi H, Takeuchi T, Takahara T, Suto A, Kodaira S, Ishibiki K. Gan To Kagaku Ryoho; 1991 Oct; 18(13):2247-53. PubMed ID: 1929445 [Abstract] [Full Text] [Related]
44. [Cell culture and its application--in vitro evaluation of anticancer activity using human tumor cell lines]. Tashiro T. Gan To Kagaku Ryoho; 1992 Oct; 19(12):2107-12. PubMed ID: 1329672 [Abstract] [Full Text] [Related]
45. [Demonstration of succinate dehydrogenase activity in ascites tumor cells using fluorescent tetrazolium salts]. Langer EM. Acta Histochem; 1985 Oct; 76(1):23-8. PubMed ID: 3925697 [Abstract] [Full Text] [Related]
46. Cytotoxicity of mitomycin C and carboquone combined with hyperthermia against hypoxic tumor cells in vitro. Sakaguchi Y, Kohnoe S, Emi Y, Maehara Y, Kusumoto T, Sugimachi K. Oncology; 1992 Oct; 49(3):227-32. PubMed ID: 1495751 [Abstract] [Full Text] [Related]
47. Optimal conditions of chemotherapeutic sensitivity in K562 cell line using tetrazolium dye assay. Yu D, Yu LL. Zhongguo Yao Li Xue Bao; 1993 Mar; 14(2):137-40. PubMed ID: 8352006 [Abstract] [Full Text] [Related]
48. Antitumor chemosensitivity differs between clinical sarcoma and adenocarcinoma tissues. Takeuchi H, Baba H, Inutsuka S, Takahashi I, Kusumoto H, Maehara Y, Sugimachi K. Anticancer Res; 1994 Mar; 14(1A):169-71. PubMed ID: 8166444 [Abstract] [Full Text] [Related]
54. [Results of random screening of antineoplastic agents in Japan. The sixth report]. Gan To Kagaku Ryoho; 1994 Jul; 21(9):1301-556. PubMed ID: 8067784 [No Abstract] [Full Text] [Related]
57. [A trial of isolation in chemotherapy for gynecological malignant tumor by MTT assay]. Sato Y, Igarashi S, Higuchi J, Soga K, Tanaka T. Nihon Sanka Fujinka Gakkai Zasshi; 1993 Dec; 45(12):1421-4. PubMed ID: 8270830 [No Abstract] [Full Text] [Related]
58. Use of the succinate dehydrogenase inhibition test in assessing the heat sensitivity of tumor cells. Kohnoe S, Maehara Y, Takahashi I, Yoshida M, Emi Y, Kusumoto T, Sugimachi K. Oncology; 1993 Dec; 50(6):500-4. PubMed ID: 8233294 [Abstract] [Full Text] [Related]
59. [Inhibition of the succino-dehydrogenase of animal tumors and normal tissues by 4-hydroxypentenal]. Kapfer E, Schauenstein E. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1972 Dec; 77(3):180-8. PubMed ID: 4262172 [No Abstract] [Full Text] [Related]
60. Antineoplastic drug screening. Adams DJ. J Natl Cancer Inst; 1992 Aug 19; 84(16):1288-90. PubMed ID: 1640490 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]